Tag: the war on (some) drugs

Indiana Lawmakers Weigh Widespread Ban On All Marijuana Advertising, Not Just On Billboards

Indiana lawmakers could ban all marijuana advertising within state lines under an amendment adopted Monday in a transportation-focused committee. It goes beyond the billboard-specific prohibition taken in a Senate panel last week.

Rep. Jim Pressel (R-Rolling Prairie) said his community is “inundated” with billboards advertising illegal marijuana. The district is near Michigan, which has legalized it.

But that’s not all.

“My constituents, myself included, receive up to two—what would look like political mailers—a week advertising an illegal substance” at dispensaries in nearby New Buffalo, per Pressel. He chairs the House Roads and Transportation Committee.

He commandeered Senate Bill 73, dealing with utility trailer sales, for an amendment outlawing the advertising of marijuana and other drugs on Indiana’s list of Schedule I controlled substances. Indiana’s attorney general could sue for injunctions, civil penalties of up to $15,000 and “reasonable costs” incurred throughout the investigation and lawsuit.

“I’ve heard about [how] the First Amendment, I’m trampling on it. I don’t believe that to be true,” Pressel told the committee. He cited a federal appeals court decision that, “basically, if it’s a criminal activity, you have no First Amendment right to advertise. That’s my understanding.”

The ban would take effect upon the bill’s passage. Advertising from contracts entered into or renewed before the approval date would be exempt.

The committee accepted the edits by consent.

Keep reading

Trump’s New White House Drug Czar Called Medical Marijuana A ‘Fantastic’ Treatment For Cancer Patients

President Donald Trump’s choice to serve as the next White House drug czar has called medical marijuana a “fantastic” treatment option for seriously ill patients and said she doesn’t have a “problem” with legalization, even if she might not personally agree with the policy.

Trump picked Sara Carter, a journalist known for her coverage of drug cartels, to serve as director of the Office of National Drug Control Policy (ONDCP).

The president said Carter has “been on the front lines of this International Fight for decades” and ” will lead the charge to protect our Nation.”

Given the role of ONDCP director in setting and carrying out the administrative agenda on drug policy issues, the fact that Carter has gone on the record enthusiastically endorsing medical cannabis will likely be welcome news for advocates amid the Senate confirmations of officials with a mixed bag of marijuana records.

Under longstanding federal statute, the drug czar is prohibited from endorsing the legalization of Schedule I drugs in the Controlled Substances Act (CSA), including marijuana.

“The Director…shall ensure that no Federal funds appropriated to the Office of National Drug Control Policy shall be expended for any study or contract relating to the legalization (for a medical use or any other use) of a substance listed in schedule I of section 812 of this title and take such actions as necessary to oppose any attempt to legalize the use of a substance (in any form) that— (A) is listed in schedule I of section 812 of this title; and (B) has not been approved for use for medical purposes by the Food and Drug Administration.”

Trump himself has previously expressed support for medical cannabis, as well as rescheduling of marijuana under federal law.

Keep reading

New Hampshire Governor Reiterates Opposition To Marijuana Legalization, But May Consider Allowing Medical Homegrow

As bills to legalize marijuana for adults in New Hampshire makes their way through the legislature, Gov. Kelly Ayotte (R) is reiterating her opposition to the reform—but is also signaling that she may be open to separate legislation that would allow medical cannabis patients to grow their own medicine at home.

“I’ve been very clear on this,” Ayotte told reporters last Wednesday, the same day House lawmakers passed HB 198, which would legalize the use and possession of marijuana by adults 21 and older. “I ran on this issue, and the people of New Hampshire know where I stand on it. I don’t support it.”

A former U.S. senator and state attorney general, Ayotte said repeatedly on the campaign trail last year that she would oppose efforts at adult-use legalization.

HB 198 would, if enacted, allow adults 21 and older to possess up to two ounces of marijuana flower, 10 grams of concentrate and up to 2,000 milligrams of THC in other cannabis products. Retail sales of marijuana products, along with home cultivation, would remain illegal. Consuming marijuana on public land would also be prohibited.

The proposal, from Rep. Jared Sullivan (D), cleared the chamber last week in a 208–125 vote.

Ayotte said there were a number of reasons she’s against the change, according to a report from the outlet InDepthNH.

“I don’t think it is the right direction for the state for a lot of reasons,” she told reporters. “I believe, if you think about our quality of life, if you think about some of the concerns that can flow from that. I know…we talked about safety on our roadways. I think that there are a number of issues that states who have legalized cannabis have experienced in those regards that I just don’t think can be addressed at the moment with the existing technology.”

The governor of the Granite State also added that she’s “mindful of the message we send to younger people when we legalize something versus it being illegal.”

Despite Ayotte’s comments flatly opposing legalization, however, she left the door open to more modest cannabis reform. She told reporters she will review every bill that comes to her desk, including a separate House-passed measure that would legalize home cultivation by state-registered medical marijuana patients.

That bill—HB 53, from Rep. Wendy Thomas (D), would allow cultivation of up to three mature plants and three immature plants, as well as 12 seedlings. Patients could also possess up to eight ounces of usable cannabis from those plants.

Keep reading

GOP Senator Paints Dire Picture Of Medical Marijuana Legalization In His State, Saying Voters Didn’t Understand ‘Consequences’

U.S. Sen. James Lankford (R-OK) said at an event on Friday that voters in his home state didn’t understand what they were doing when they legalized medical marijuana in 2018.

Pointing to a new report from the Texoma High Intensity Drug Trafficking Area (HIDTA) program, which covers north Texas and Oklahoma, Lankford said the state has been overrun by growers and dispensaries and has “seen rising crime, human trafficking [and] illegal migration coming into our state” since the law took effect.

Although citizens voted in favor of medical marijuana legalization, he said, “I don’t think a lot of Oklahomans realized, when that vote actually occurred, what the consequences of that would be.”

The senator’s comments are in keeping with criticisms that Republican politicians in Oklahoma have levied against medical marijuana for years. In 2022, for example, Gov. Kevin Stitt (R) similarly suggested that state residents misunderstood the cannabis initiative they voted to enact.

Stitt said at the time that he was directing law enforcement to “crack down hard on the black market,” adding that “drug cartels, organized crime, foreign bad actors have no place in the state of Oklahoma.”

But in comments on Friday, Lankford—a longtime critic of legalization—painted a dire picture of what’s happening in the state.

“The findings that are coming out are stark,” he said of the new HIDTA report. “We have Chinese criminal organizations and organized crime that has moved in to Oklahoma in just the last six years, in numbers that have skyrocketed.”

That’s led to what he described as “execution-style murders in rural areas of the state” that are connected “directly to marijuana grows and what is happening here on the ground.”

“We, as a state, have to decide what we’re going to do about it,” the federal lawmaker said. “We have hard decisions to be able to make on what we’re going to do to be able to protect our kids in the days ahead… This is a very serious issue that we need to be able to take on and to be able to address.”

Keep reading

Canadian Banks Linked To Chinese Fentanyl Laundering Risk US Treasury Sanctions After Cartel Terror Designation

In an explosive interview with The Bureau’s Sam Cooper, David Asher – a former senior U.S. State Department official with close ties to the Trump administration’s financial and national security apparatus—issued a stark warning: Canadian banks could soon face a “new universe” of regulatory scrutiny from the U.S. Treasury. This follows the formal designation of Mexican cartels, including the Sinaloa group, as Foreign Terrorist Organizations (FTOs). According to Asher, the command-and-control structure for laundering proceeds from synthetic narcotics—produced using Chinese precursor chemicals—is largely orchestrated by Chinese triads operating out of Canada.

Asher warned that these transnational crime gang nexus seriously threatens both U.S. national security and the stability of the North American financial system. 

Keep reading

Texas Lieutenant Governor Says He’ll Push For Special Session To Pass Hemp Product Ban

Texas Lt. Gov. Dan Patrick (R) said he will move to force an overtime session of the Legislature if lawmakers fail to ban THC or tighten Texas’s bail laws—two of his top priorities—before the current session ends in early June.

The power to order lawmakers back to Austin for a special session is reserved for Gov. Greg Abbott (R), who also gets to set the agenda for such overtime rounds. But in his role presiding over the Texas Senate, Patrick can block any bill from passing, giving him leverage to compel special sessions by killing must-pass legislation.

Patrick did exactly that in 2017, thwarting passage of a “sunset” bill that would have extended the life of several state agencies, including the Texas Medical Board, after the House declined to take up measures curbing property tax rates and requiring transgender people to use public restrooms based on “biological sex” rather than their gender identities.

In an interview, Patrick affirmed that he would go a similar route this session if the House declines to get on board with his priority bill to clamp down on the state’s exploding hemp market by banning products that contain tetrahydrocannabinol, or THC.

“There aren’t many things you go down that path for, but the life and health of people is one,” Patrick told The Texas Tribune on Wednesday. “I couldn’t, in good conscience, leave here knowing if we don’t do something about it in the next two years—how many kids get sick?”

Patrick and Senate lawmakers are taking aim at the roughly 8,300 Texas retailers that sell a range of hemp products—from gummies to beverages to flower buds—under a 2019 state law that authorized the sale of consumable hemp. Patrick and Sen. Charles Perry, the Lubbock Republican who carried the 2019 law, say the hemp industry has exploited a loophole in a bill that was intended to boost agriculture by allowing non-consumable products with small amounts of delta-9 THC.

While hemp products are not allowed to contain more than a 0.3 percent concentration of THC—anything higher is classified as marijuana—Patrick and Perry contend that the industry has endangered public health by putting products on the shelf with dangerously high levels of THC well beyond the 0.3 percent threshold.

Perry’s proposal this session, known as Senate Bill 3, would effectively shutter the hemp industry by making it illegal to possess or manufacture products containing THC outside the state’s limited medical marijuana program.

It’s already passed in the Senate, but it awaits action in the lower chamber, where industry leaders are hopeful House members will push for stricter oversight and licensing requirements in lieu of banning THC products altogether.

Keep reading

New York Movie Theaters Could Sell Marijuana And Allow Consumption During Films Under Forthcoming Licenses, Official Says

A New York official says there are plans in the works to expand permitting and licensing rules that could allow adults to buy and consume marijuana at movie theaters.

While many theaters across the country currently let moviegoers purchase and drink alcohol, that’s not the case for cannabis—even in states where marijuana has been legalized.

“At this time, cannabis can only be sold at legal, licensed adult-use dispensaries or legal, licensed adult-use microbusinesses,” New York Office of Cannabis Management (OCM) Press Secretary Taylor Randi Lee told Variety.

“For theaters to serve recreational marijuana at their establishments, they would need either an events permit or consumption lounge license,” she was quoted as saying in a story the trade publication ran about ways that theaters can appeal to audiences to buy tickets. “New York State does not have either yet but plans to in the future.”

The idea of potentially expanding permitting to authorize sales of cannabis products at movie theaters would set New York apart as it continues to build upon the state’s legalization law.

OCM’s comments come days after Gov. Kathy Hochul (D) signed a pair of companion bills into law that are meant to expand New York’s marijuana farmers market program, allowing for more partnerships between licensed cannabis businesses and standalone “pop-up” events.

Keep reading

Trump White House Says Marijuana Decriminalization ‘Opened The Door To Disorder’ In Washington, D.C.

President Donald Trump’s White House says the move to decriminalize marijuana in Washington, D.C. is an example of a “failed” policy that “opened the door to disorder.”

In a fact sheet about an executive order that Trump signed on Friday—which is broadly aimed at beautifying the District and making it more safe—the White House listed several local policies in the nation’s capital that it takes issue with, including cannabis reform. That’s despite the president’s previously stated support for a states’ rights approach to marijuana laws.

“D.C.’s failed policies opened the door to disorder—and criminals noticed,” it says, citing “marijuana decriminalization,” as well as the District’s decision to end pre-trial detentions and enforcement practices around rioters, as examples of such policies.

The executive order itself doesn’t mention marijuana specifically. But it says the directive will involve “deploying a more robust Federal law enforcement presence and coordinating with local law enforcement to facilitate the deployment of a more robust local law enforcement presence as appropriate in areas in or about” D.C., and that includes addressing “drug possession, sale, and use.”

With respect to the fact sheet circulated by the White House, cannabis possession and personal cultivation is legalized in D.C. under a voter-approved ballot initiative, though commercial sales of non-medical marijuana remain illegal (a policy referred to by some as “decriminalization”).

Because of a long-standing congressional rider that’s been annually renewed since that vote, the District hasn’t been able to use local funds to implement a system of regulated recreational cannabis sales, so officials have taken steps to expand the city’s existing medical marijuana program as a workaround.

Keep reading

Iowa Lawmakers Unanimously Approve Bill To Create Psilocybin Program That Would Treat Up To 5,000 Patients With PTSD

An Iowa House committee has unanimously approved a Republican-led proposal to create a state-regulated therapeutic psilocybin program for adults with PTSD.

The bill, HF 620, from Rep. John Wills (R), passed the House Ways and Means Committee on a 23–0 vote at a hearing Thursday.

If enacted into law, it would allow up to 5,000 patients in the state to legally access psilocybin produced in-state by licensed entities. Administration sessions would need to be supervised by registered facilitators—mostly medical professionals—who would need to complete state-specified psilocybin education.

Psilocybin providers would need to be doctors, advanced nurse practitioners, advanced practice nurses, psychologists or social workers who complete psilocybin continuing education requirements, register with the state and pay a registration fee.

Administration sessions themselves would need to be at registered clinical locations and would need to be video recorded. Those records would need to be available for inspection by state officials upon request.

The psilocybin itself would be produced by state-licensed establishments. Local governments could not outright ban those facilities, nor could they deny them appropriate licenses based merely on the fact that psilocybin violates federal law.

Notably, a licensed psilocybin production facility could be co-located with one of the state’s few licensed medical cannabis producers—known in Iowa as medical cannabidiol producers—and the bill says regulators may grant psilocybin licensing preferences to those existing cannabis producers. Facilities couldn’t be located within 1,000 feet of a community location or 500 feet of a residential area.

Only people 21 and older and without “a misdemeanor for drug distribution or any felony” could work at psilocybin producers, and licensees themselves would face background checks.

Up to four independent testing labs could be licensed under the bill, and the state could also establish its own lab.

License applications would be accepted beginning July 1, 2026.

To oversee the system, the legislation would create a state Psilocybin Production Establishment Licensing Board under the Iowa Department of Health and Human Services (HHS).

Appointed by the director of that department, the board would include a member of the public with knowledge of psilocybin, a member with knowledge and experience in the pharmaceutical or nutraceutical manufacturing industry, a law enforcement member, a university chemist or researcher with experience in manufacturing, a member who has a background in fungus or mushroom cultivation and processing.

Keep reading